Zhao J - Search Results

1

The clinical utility of dynamic ctDNA monitoring in inoperable localized NSCLC patients.

Yang Y, Zhang T, Wang J, Wang J, Xu Y, Zhao X, Ou Q, Shao Y, Wang X, Wu Y, Wu L, Xu X, Xu K, Zhao J, Wang L, Bi N. Yang Y, et al. Among authors: zhao j, zhao x. Mol Cancer. 2022 May 19;21(1):117. doi: 10.1186/s12943-022-01590-0. Mol Cancer. 2022. PMID: 35590322 Free PMC article. No abstract available.

2

Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.

Wang Y, Zhang T, Huang Y, Li W, Zhao J, Yang Y, Li C, Wang L, Bi N. Wang Y, et al. Among authors: zhao j. Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1154-1164. doi: 10.1016/j.ijrobp.2021.12.150. Epub 2021 Dec 26. Int J Radiat Oncol Biol Phys. 2022. PMID: 34963558

3

Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Yang Y, Wang J, Wang W, Zhang T, Zhao J, Wang Y, Li Y, Wang L, Bi N. Yang Y, et al. Among authors: zhao j. Front Oncol. 2022 Jan 28;12:810580. doi: 10.3389/fonc.2022.810580. eCollection 2022. Front Oncol. 2022. PMID: 35155246 Free PMC article.

4

Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis.

Yang Y, Wang J, Wang W, Zhang T, Zhao J, Wang Y, Li Y, Wang L, Bi N. Yang Y, et al. Among authors: zhao j. Front Oncol. 2022 Aug 24;12:1007862. doi: 10.3389/fonc.2022.1007862. eCollection 2022. Front Oncol. 2022. PMID: 36091135 Free PMC article.

5

Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor.

Zhao J, Zhang W, Er P, Chen X, Guan Y, Qian D, Wang J, Yuan Z, Zhao L, Wang P, Pang Q. Zhao J, et al. Among authors: zhao l. J Cancer. 2020 Jun 16;11(17):4957-4964. doi: 10.7150/jca.41136. eCollection 2020. J Cancer. 2020. PMID: 32742443 Free PMC article.

6

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.

Chen Y, Zhao J, Jiao Z, Wang W, Wang D, Yu X, Shi Z, Ge N, Pan Q, Xia J, Niu W, Zhao R, Zhang X, Du W. Chen Y, et al. Among authors: zhao j, zhao r. BMC Cancer. 2018 Dec 11;18(1):1240. doi: 10.1186/s12885-018-5119-6. BMC Cancer. 2018. PMID: 30537941 Free PMC article.

7

Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03).

Zhang W, Zhao J, Han W, Zhang H, Wang X, Li C, Chen J, Wang X, Zhao Y, Qiao X, Zhou Z, Han C, Zhu S, Shen W, Wang L, Ge X, Sun X, Zhang K, Hu M, Li L, Hao C, Li G, Xu Y, Wang Y, Lu N, Liu M, Qian S, Xiao Z, Wang P, Pang Q. Zhang W, et al. Among authors: zhao j, zhao y. Ann Transl Med. 2020 Sep;8(18):1140. doi: 10.21037/atm-20-4672. Ann Transl Med. 2020. PMID: 33240989 Free PMC article.

8

Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis.

Zhao JJ, Zhou S, Chen CL, Zhang HX, Zhou ZQ, Wu ZR, Liu Y, Pan QZ, Zhu Q, Tang Y, Xia JC, Weng DS. Zhao JJ, et al. J Cancer. 2018 Oct 20;9(22):4204-4214. doi: 10.7150/jca.25790. eCollection 2018. J Cancer. 2018. PMID: 30519321 Free PMC article.

9

Optimal timing of antiviral therapy for patients with malignant tumor who presented with hepatitis B reactivation during chemotherapy and/or immunosuppressive therapy.

Zou X, Guo L, Gu Y, Yang Z, Huang P, Liu T, Zhao J, Wu G. Zou X, et al. Among authors: zhao j. J Cancer. 2020 Mar 15;11(12):3559-3566. doi: 10.7150/jca.40154. eCollection 2020. J Cancer. 2020. PMID: 32284752 Free PMC article.

10

CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.

Li H, Luo F, Jiang X, Zhang W, Xiang T, Pan Q, Cai L, Zhao J, Weng D, Li Y, Dai Y, Sun F, Yang C, Huang Y, Yang J, Tang Y, Han Y, He M, Zhang Y, Song L, Xia JC. Li H, et al. Among authors: zhao j. J Immunother Cancer. 2022 Mar;10(3):e004029. doi: 10.1136/jitc-2021-004029. J Immunother Cancer. 2022. PMID: 35277458 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,439 results

Search Page

Filters